Skip to main content
. 2018 Mar 30;27(1):4–24. doi: 10.7570/jomes.2018.27.1.4

Table 1.

Clinical studies examining the association between sleep duration with obesity and diabetes

Author (year) Type of study/country or region Study population (sample size) Definition of sleep disturbances Method of sleep assessment Age (yr) and male (%) Outcome
Sleep duration and overweight/obesity
 Ayas et al. (2003)11 Prospective (mean follow-up: 10 yr)/the United States Female married registered nurses from the Nurses’ Health Study (n=70,026) Short sleep: ≤5 hr/day
Long sleep: ≥9 hr/day
Reference: 8 hr/day
Self-reported sleep duration 40–65, 0% New-onset obesity
 Short sleep: RR, 1.18; 95% CI, 0.96–1.44
 Long sleep: RR, 1.29; 95% CI, 1.05–1.59
 Patel et al. (2006)56 Prospective study (follow-up: 16 yr)/the United States Female nurses from the Nurses’ Health Study (n=68,183) Sleep duration was categorized as: ≤5, 6, 7, 8, and ≥9 hr/day
Reference: 7 hr/day
Self-reported 39–65, 0% New-onset obesity
 Sleep duration ≤5 hr/day: HR, 1.15; 95% CI, 1.04–1.27
 Sleep duration 6 hr/day: HR, 1.06; 95% CI, 1.01–1.12
 Sleep duration ≥9 hr/day: HR, 1.03; 95% CI, 0.93–1.14
≥15 kg weight gain
 Sleep duration ≤5 hr/day: HR, 1.28; 95% CI, 1.15–1.42
 Sleep duration 6 hr/day: HR, 1.10; 95% CI, 1.04–1.17
 Sleep duration ≥9 hr/day: HR, 1.04; 95% CI, 0.92–1.16
 Chaput et al. (2008)57 Prospective study (follow-up: 6±0.9 yr)/Canada General population form the Quebec Family Study (n=276; nonobese: n=224) Short sleep: 5–6 hr/day
Long sleep: 9–10 hr/day
Reference: 7–8 hr/day
Self-reported 21–64, 42.4% Weight gain
 Short-duration sleepers gained 1.84 kg; 95% CI, 1.08–2.61
 Long-duration sleepers gained 1.49 kg; 95% CI, 0.92–2.48
New-onset obesity
 Short-duration sleepers: OR, 1.27; 95% CI, NS
 Long-duration sleepers: OR, 1.21; 95% CI, NS
 López-García et al. (2008)58 Prospective study (follow-up: 2 yr)/Spain Elderly population (n=3,235) Sleep duration was categorized as: ≤5, 6, 7, 8, 9, and ≥10 hr/day
Reference: 7 hr/day
Interview Male, 71.6±8.0; female, 72.1±7.6, 43.6% ORs of obesity
 Sleep ≤5 hr: OR, 1.33; 95% CI, 1.00–1.77
 Sleep 8 hr: OR, 1.39; 95% CI, 1.11–1.75
ORs of severe obesity
 Sleep ≤5 hr: OR, 2.08; 95% CI, 1.31–3.32
 Sleep 8 hr: OR, 1.82; 95% CI, 1.21–2.73
 Sleep 9 hr: OR, 1.57; 95% CI, 1.00–2.47
Weight gain ≥5 kg
 In women sleeping ≤5 hr: OR, 3.41; 95% CI, 1.34–8.69
 In women sleeping 8 hr: OR, 3.03; 95% CI, 1.29–7.12
 In women sleeping 9 hr: OR, 3.77; 95% CI, 1.55–9.17
 In total or men: no significant findings
 Stranges et al. (2008)59 Prospective study (follow-up: 1997–1999 to 2003–2004)/the United Kingdom White-collar British civil servants from the Whitehall II Study (n=10,308) Short sleep: ≤5 hr/day
Normal sleep: 7 hr/day
Self-reported 35–55, 72.1% Changes in BMI
 Short sleep: β, –0.06; 95% CI, −0.26–0.14
Changes in WC
 Short sleep: β, 0.44; 95% CI, −0.23–1.12
New-onset obesity
 Short sleep: OR, 1.05; 95% CI, 0.60–1.82
 Nishiura et al. (2010)60 Prospective study (follow-up: 4 yr)/Japan Nonobese Japanese male workers (n=2,632) Short sleep: <6 hr/day
Normal sleep: 7–7.9 hr/day
Self-reported 40–59, 100% New-onset obesity
 Short sleep: OR, 2.46; 95% CI, 1.41–4.31
 Watanabe et al. (2010)61 Prospective study (follow-up: 1 yr)/Japan Employees for an electric power company (n=23,212) Sleep duration was categorized as: <5, 5–<6, 6–<7, 7–<8, 8–<9, and ≥9 hr/day
Reference: 7–<8 hr/day
Self-reported 39.8±9.6, 86.3% Weight gain
 Male with sleep <5 hr/day: β, 0.016; 95% CI, 0.024–0.146; P<0.01
 Male with sleep <5 hr/day: β, 0.013; 95% CI, 0.001–0.061; P=0.04
 Male with sleep ≥9 hr/day: β, 0.018; 95% CI, 0.079–0.340; P<0.01
New-onset obesity
 Male with sleep <5 hr/day: OR, 1.91; 95% CI, 1.36–2.67
 Male with sleep 5–6 hr/day: OR, 1.50; 95% CI, 1.24–1.80
 No significant association between sleep duration and weight gain or obesity was found for women.
 Itani et al. (2011)62 Prospective study (follow-up: 7 yr)/Japan Workers in a local government organization (n=22,743) Short sleep: <5 hr/day
Normal sleep: 5–7 hr/day
Self-reported NS, 95.4% New-onset obesity
 Male subjects with short sleep: RR, 1.20; 95% CI, 1.09–1.32
 Female subjects with short sleep: RR, 1.71; 95% CI, 1.11–2.87
 Lyytikäinen et al. (2011)63 Prospective study (follow-up: 5–7 yr)/Finland Middle-aged municipal employees from the Helsinki Health Study (n=7,027) Short sleep: ≤5 hr/day
Long sleep: ≥9 hr/day
Reference: 7 hr/day
Self-reported 40–60, 18.5% Weight gain ≥5 kg
 Female with short sleep: OR, 1.42; 95% CI, 1.01–2.01
 Female with long sleep: OR, 1.30; 95% CI, 0.97–1.76
 Male with short sleep: OR, 0.88; 95% CI, 0.44–1.74
 Male with long sleep: OR, 1.06; 95% CI, 0.48–2.32
 Kobayashi et al. (2012)64 Prospective study (follow-up: 3 yr)/Japan Healthy population (n=11,136) Sleep duration was categorized as: ≤5, 6, 7, and ≥8 hr/day
Reference: 7 hr/day
Self-reported ≥20, 44.0% Weight gain
 Sleep ≤5: β coefficient, 0.03; 95% CI, 0.03–1.1; P=0.02
 Sleep ≥8: β coefficient, 0.01; 95% CI, −0.03–0.1; P=0.34
New-onset obesity
 Sleep ≤5: OR, 1.5; 95% CI, 1.1–2.0
 Sleep ≥8: OR, 1.3; 95% CI, 0.9–1.8
 Yiengprugsawan et al. (2012)65 Prospective study (follow-up: 4 yr)/Thailand Distance learners at Sukhothai Thammathirat Open University (n=60,569) Sleep duration was categorized as <6, 6, 7, 8 and ≥9 hr/day;
Short sleep: <6 hr/day
Long sleep: ≥9 hr/day
Reference: 7 hr/day
Self-reported 35.6 (20–49), 45.2% Overweight
 Female with short sleep: OR, 1.33; 95% CI, 1.18–1.51
 Female with long sleep: OR, 1.22; 95% CI, 1.07–1.39
 Male with short sleep: OR, 1.13; 95% CI, 1.00–1.28
 Male with long sleep: OR, 1.03; 95% CI, 0.91–1.16
New-onset obesity
 Female with short sleep: OR, 1.49; 95% CI, 1.32–1.68
 Female with long sleep: OR, 1.36; 95% CI, 1.20–1.53
 Male with short sleep: OR, 1.36; 95% CI, 1.21–1.52
 Male with long sleep: OR, 1.16; 95% CI, 1.03–1.30
 Nagai et al. (2013)66 Prospective study (follow-up: 11 yr)/Japan General population (n=9,658) Short sleep: ≤5 hr/day
Long sleep: ≥9 hr/day
Reference: 7 hr/day
Self-reported 40–79, NS Weight gain ≥5 kg
 Total subjects with short sleep: OR, 0.93; 95% CI, 0.73–1.20
 Total subjects with long sleep: OR, 1.05; 95% CI, 0.91–1.20
 BMI ≥25 kg/m2 with short sleep: OR, 0.86; 95% CI, 0.58–1.29
 BMI ≥25 kg/m2 with long sleep: OR, 1.36; 95% CI, 1.09–1.70
New-onset obesity
 Short sleep: OR, 1.08; 95% CI, 0.77–1.51
 Long sleep: OR, 1.06; 95% CI, 0.86–1.29
 Ohkuma et al. (2013)67 Cross-sectional study/Japan Japanese patients with T2DM (n=4,870) Sleep duration was categorized as: <4.5, 4.5–5.4, 5.5–6.4, 6.5–7.4, 7.5–8.4, and ≥8.5 hr/day;
Reference: 6.5–7.4 hr/day
Self-reported ≥20, 57% ORs (95% CIs) for obesity
 Sleep <4.5 hr/day: OR, 1.78; 95% CI, 1.26–2.52
 Sleep ≥8.5 hr/day: OR, 1.24; 95% CI, 0.97–1.58
P for quadratic trend: <0.001
 Sayón-Orea et al. (2013)68 Prospective study (median follow-up: 6.5 yr)/Spain General population from the SUN Mediterranean Cohort (n=10,532) Sleep duration was categorized as <5, 5–<7, 7–<8, ≥8 hr/night; Reference: 7–<8 hr/day Self-reported 39±12, NS New-onset obesity
 Total with sleep <5 hr/night: HR, 1.94; 95% CI, 1.19–3.18
 Male with sleep <5 hr/night: HR, 2.09; 95% CI, 1.18–3.69
 Female with sleep <5 hr/night: HR, 1.26; 95% CI, 0.44–3.57
 Total with sleep ≥8 hr/night: HR, 1.13; 95% CI, 0.89–1.43
 Male with sleep ≥8 hr/night: HR, 0.88; 95% CI, 0.64–1.21
 Female with sleep ≥8 hr/night: HR, 1.43; 95% CI, 0.97–2.10
 Xiao et al. (2013)69 Prospective study (follow-up: 7.5 yr)/the United States General population from the National Institutes of Health-AARP Diet and Health Study (n=83,377) Sleep duration was categorized as <5, 5–6, 7–8, ≥9 hr/day;
Reference: 7–8 hr/day
Self-reported 51–72, 51.8% Weight gain ≥5 kg
 Male with sleep <5 hr/day: OR, 1.27; 95% CI, 1.07–1.52
 Female with sleep <5 hr/day: OR, 1.30; 95% CI, 1.12–1.51
 Male with sleep ≥9 hr/day: OR, 1.16; 95% CI, 0.99–1.36
 Female with sleep ≥9 hr/day: OR, 1.02; 95% CI, 0.88–1.17
New-onset obesity
 Male with sleep <5 hr/day: OR, 1.45; 95% CI, 1.06–1.99
 Female with sleep <5 hr/day: OR, 1.37; 95% CI, 1.04–1.79
Sleep duration ≥9 hr/day
 Male with sleep ≥9 hr/day: OR, 1.12; 95% CI, 0.84–1.49
 Female with sleep ≥9 hr/day: OR, 0.91; 95% CI, NS
 Vgontzas et al. (2014)70 Prospective study (total follow-up: 7.5 yr; women: 4.5 yr; men: 10.5 yr)/the United States General population from the Penn State Cohort (n=815) Sleep duration was categorized as ≤5, 5–6, 6–7, ≥7 hr/night;
Reference: ≥7 hr/night
Self-reported (subjective) and PSG (objective) 48.9±13.4, 50.5% New-onset obesity
 Subjective sleep duration ≤5 hr/night: OR, 1.08; 95% CI, 0.48–2.41
 Objective sleep duration ≤5 hr/night: OR, 0.51; 95% CI, 0.22–1.18
 Gutiérrez-Repiso et al. (2014)71 Prospective study (follow-up: 11 yr)/Spain General population from the Pizarra cohort study (n=1,145) Short sleep: ≤7 hr/night Normal sleep: ≥8 hr/night Self-reported 18–65, 38.8% ORs of becoming obese in subjects with short sleep
 At the 6-yr follow-up: OR, 1.99; 95% CI, 1.12–3.55
 At the 11-yr follow-up: OR, 2.73; 95% CI, 1.47–5.04
 Kim et al. (2015)72 Prospective study (follow-up: 2.6 yr)/Korea General population from the ARIRANG Study (n=3,862) Short sleep: <6 hr/day
Long sleep: ≥10 hr/day
Reference: 6–7.9 hr/day
Self-reported 40–70, 41.1% New-onset metabolic syndrome
 Short sleep: OR, 1.41; 95% CI, 1.06–1.88
 Long sleep: OR, 0.68; 95% CI, 0.39–1.17
High WC
 Short sleep: OR, 1.30; 95% CI, 0.98–1.69
 Long sleep: OR, 0.97; 95% CI, 0.62–1.50
 Zhang et al. (2015)73 Cross-sectional study/China School-aged children (n=3,086) Sleep duration was categorized as: ≤8.00, 8.01–9.00, 9.01–10.00, and >10 hr/night;
Reference: >10 hr/night
Sleep compensated group: (weekend [or holiday] sleep duration–weekday sleep duration)/weekday sleep duration×100% ≥10%
Reference: noncompensated group
Self-reported 7–14, 52.1% Risk of being overweight/obese
 Weekdays sleep ≤8.00 hr/night: OR, 1.995; 95% CI, 0.917–4.219
 Weekends sleep ≤8.00 hr/night: OR, 2.691; 95% CI, 1.513–4.785
 Long holidays sleep ≤8.00 hr/night: OR, 2.921; 95% CI, 1.630–5.323
 Sleep compensation during weekends: OR, 1.197; 95% CI, 1.004–1.493
 Sleep compensation during holidays: OR, 1.309; 95% CI, 1.052–1.630

Sleep duration and risk of diabetes
 Ayas et al. (2003)11 Prospective (mean follow-up: 10 yr)/the United States Female married registered nurses from the Nurses’ Health Study (n=70,026) Short sleep: ≤5 hr/day
Long sleep: ≥9 hr/day
Reference: 8 hr/day
Self-reported 40–65, 0% New-onset symptomatic diabetes
 Short sleep: RR, 1.34; 95% CI, 1.04–1.72
 Long sleep: RR, 1.35; 95% CI, 1.04–1.75
 Mallon et al. (2005)74 Prospective (mean follow-up: 12 yr)/Sweden General population (n=1,170) Short sleep: ≤5 hr/night
Long sleep: ≥9 hr/night
Reference: 5–8 hr/night
Self-reported 45–65, 47.0% New-onset diabetes
 Male with short sleep: RR, 2.8; 95% CI, 1.1–7.3
 Female with short sleep: RR, 1.8; 95% CI, 0.5–6.8
 Male with long sleep: NS
 Female with long sleep: RR, 2.9; 95% CI, 0.6–15.0
 Yaggi et al. (2006)75 Prospective study (follow-up: 15–17 yr)/the United States Men from the Massachusetts Male Aging Study without diabetes (n=1,139) Average sleep duration was divided into: ≤5, 6, 7, 8, and >8 hr/night;
Reference: 7 hr/night
Self-reported 40–70, 100% New-onset diabetes
 Sleep ≤5 hr/night: RR, 1.95; 95% CI, 0.95–4.01
 Sleep >8 hr/night: RR, 3.12; 95% CI, 1.53–6.37
Further adjusted for testosterone
 Sleep ≤5 hr/night: RR, 1.51; 95% CI, 0.71–3.19
 Sleep >8 hr/night: RR, 2.81; 95% CI, 1.34–5.90
 Gangwisch et al. (2007)76 Prospective study (follow-up: 8–10 yr)/the United States General population from the First National Health and Nutrition Examination Survey I (n=8,992) Short sleep: ≤5 hr/night
Long sleep: ≥9 hr/night
Reference: 7 hr/night
Self-reported 32–86, 37% New-onset diabetes
 Short sleep: OR, 1.47; 95% CI, 1.03–2.09
 Long sleep: OR, 1.52; 95% CI, 1.06–2.18
 Hayashino et al. (2007)77 Prospective study (median follow-up: 4.2 yr)/Japan Asian workers from High-risk and Population Strategy for Occupational Health Promotion Study (n=6,509) Short sleep: sleep duration <6 hr/day
Long sleep: ≥9 hr/day
Reference: 6–7 hr/day
Self-reported 38.2 (19–69), 73.9% New-onset diabetes
 Short sleep: HR, 1.15; 95% CI, 0.76–1.74
 Long sleep: HR, 1.03; 95% CI, 0.62–1.70
 Beihl et al. (2009)78 Prospective study (follow-up: 5 yr)/the United States General population from the Insulin
Resistance Atherosclerosis Study (n=900)
Short sleep: ≤7 hr/night
Long sleep: ≥9 hr/night
Reference: 8 hr/night
Self-reported 40–69, 43.3% New-onset diabetes
 Non-Hispanic whites and Hispanics with short sleep: OR, 2.36; 95% CI, 1.11–5.00
 Non-Hispanic whites and Hispanics with long sleep: OR, 2.15; 95% CI, 0.50–9.30
 African American with short sleep: OR, 0.63; 95% CI, 0.14–2.90
 African American with long sleep: OR, 0.39; 95% CI, 0.02–7.19
 Chaput et al. (2009)79 Longitudinal study (mean follow-up: 6.0±0.9 yr)/Canada General population from the Quebec Family Study (n=276) Short sleep: ≤6 hr/night
Long sleep: ≥9 hr/night
Reference: 7–8 hr/night
Self-reported 21–64, 42.4% New-onset T2DM or IGT
 Short sleep: OR, 2.42; 95% CI, 1.49–3.33
 Long sleep: OR, 2.31; 95% CI, 1.41–3.15
 Xu et al. (2010)80 Prospective study (follow-up: 6 yr)/the United States General population from the National Institutes of Health-American Association of Retired Persons Diet and Health cohort (n=164,399) Average sleep duration was divided into: <5, 5–6, 7–8, and ≥9 hr/night;
Reference: 7–8 hr/night
Day napping was categorized as: none, <1 hr, and ≥1 hr/day;
Reference: none
Self-reported 50–71, 56.8% New-onset diabetes
 Sleep <5 hr/night: OR, 1.34; 95% CI, 1.20–1.50
 Sleep 5–6 hr/night: OR, 1.06; 95% CI, 1.01–1.11
 Sleep ≥9 hr/night: OR, 1.09; 95% CI, 0.97–1.22
 Day napping <1 hr/day: OR, 1.23; 95% CI, 1.18–1.29
 Day napping ≥1 hr/day: OR, 1.55; 95% CI, 1.45–1.66
Hours of day napping×night sleep on diabetes: P<0.0001; among participants with no napping, only short night sleeping was associated with higher occurrence of diabetes (OR, 1.32), whereas among those with ≥1 hr of napping, both long (OR, 1.55) and short (OR, 1.78) sleeping was associated with higher risk.
 Kita et al. (2012)81 Prospective, occupational-based study (follow-up: 4 yr)/Japan Local government employees (n=3,570) Short sleep: ≤5 hr/day
Reference: >7 hr/day
Self-reported 35–55, 79.0% New-onset diabetes
 Short sleep: OR, 5.37; 95% CI, 1.38–20.91
 von Ruesten et al. (2012)82 Prospective study (mean follow-up: 7.8 yr)/Germany General population from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study (n=23,620) Short sleep: <6 hr/day
Long sleep: ≥9 hr/day
Reference: 7–<8 hr/day
Self-reported 35–65, 38.6% New-onset diabetes
 Short sleep: HR, 1.06; 95% CI, 0.80–1.40
 Long sleep: HR, 1.05; 95% CI, 0.82–1.33
 Holliday et al. (2013)83 Prospective study (mean follow-up: 2.3 yr)/Australia General population from the 45 and Up Study (n=212,388) Average sleep duration was categorized as: <6, 6–<7, 7–<8, 8–<9, 9–<10, and ≥10 hr/day;
Reference: 7–<8 hr/day
Self-reported ≥45, 47.3% New-onset diabetes
 Sleep <6 hr: HR, 1.29; 95% CI, 1.08–1.53
 Sleep ≥10 hr: HR, 1.03; 95% CI, 0.88–1.19
 Gutiérrez-Repiso et al. (2014)71 Prospective study (follow-up: 11 yr)/Spain General population from the Pizarra cohort study (n=1,145) Short sleep: ≤7 hr/night
Reference: ≥8 hr/night
Self-reported 18–65, 38.8% New-onset diabetes
 At the 6-yr follow-up, short sleep: OR, 1.96; 95% CI, 1.10–3.50
 At the 11-yr follow-up, short sleep: OR, 1.28; 95% CI, 0.60–2.69
 Heianza et al. (2014)84 Prospective study (follow-up: 8 yr)/Japan Workers (n=38,987) Average sleep duration was categorized as: <5.5, 5.5–<6.5, 6.5–<7.0, 7.0–7.5, >7.5–8.0, or >8.0 hr/day;
Short sleep: <5.5 or 5.5–<6.5 hr/day;
Reference: 7.0–7.5 hr/day
Self-reported 18–83, 64.2% New-onset diabetes
 Sleep <5.5 hr: OR, 1.53; 95% CI, 1.19–1.97
 Sleep 5.5–<6.5 hr: OR, 1.25; 95% CI, 1.10–1.42
 Sleep >8 hr/day: OR, 1.03; 95% CI, 0.81–1.30
 In age ≤45 yr, sleep <5.5 hr: OR, 1.61; 95% CI, 1.08–2.42
 In age 46–59 yr, sleep <5.5 hr: OR, 1.56; 95% CI, 1.10–2.22
 In age ≥60 yr, sleep <5.5 hr: OR, 1.72; 95% CI, 0.75–3.92
 Lou et al. (2015)85 Prospective study (median follow-up: 5 yr)/China General population (n=11,842) Short sleep: ≤6 hr/night
Long sleep: ≥8 hr/night
Reference: 6–8 hr/night
Self-reported 44.8±14.7, 45.4% New-onset T2DM
 Short sleep: RR, 1.67; 95% CI, 1.34–2.16
 Long sleep: RR, 1.45; 95% CI, 1.02–1.77
 Kim et al. (2015)72 Prospective study (follow-up: 2.6 yr)/Korea General population (n= 3,862) Short sleep: <6 hr/day
Long sleep: ≥10 hr/day
Reference: 6–7.9 hr/day
Self-reported 40–70, 41.1% High blood glucose
 Short sleep: OR, 1.31; 95% CI, 0.96–1.79
 Long sleep: OR, 0.56; 95 CI, 0.29–1.04
 Han et al. (2016)86 Prospective Study (follow-up: 3–4.75 yr)/China Retired employees from the Dongfeng-Tongji cohort (n=16,399) Sleep duration was categorized as: <7, 7–<8 (reference), 8–<9, 9–<10, and ≥10 hr/night;
afternoon napping was divided into: no napping (0 min, reference), 1–30, 31–60, 61–90, and >90 min
Self-reported 62.5, 43.2% New-onset diabetes
 Sleep <7 hr/night: HR, 0.93; 95% CI, 0.72–1.19
 Sleep ≥10 hr/night: HR, 1.42; 95% CI, 1.08–1.87
 Napping >90 min: HR, 1.28; 95% CI, 1.03–1.59
 Sleep duration ≥10 hr/night and napping >60 min: HR, 1.72; 95% CI, 1.03–2.85

Sleep duration and glycemic control
 Knutson et al. (2006)87 Cross-sectional study/the United States African-American women and men with diabetes (n=161) Perceived sleep debt: the difference between weekday sleep duration and preferred sleep duration Self-reported 57±12, 26.1% Glycemic control (lnHbA1c)
 Sleep debt in patients without diabetic complications: β, 0.51; P=0.04
 Sleep debt in patients with 1 or more diabetic complications: β, −0.005; P=0.85
 Kim et al. (2013)88 Cross-sectional study/Korea Korean patients with diabetes (n=2,134) Sleep duration was categorized as: <6, 6, 7, 8, and ≥9 hr/day;
Reference: 7 hr/day
Self-reported 61.7±12.3, 49.9% OR of high HbA1c (≥7.0%)
 Total with sleep <6 hr/day: OR, 1.15; 95% CI, 0.85–1.60
 Total with sleep ≥9 hr/day: OR, 1.38; 95% CI, 0.93–2.03
 Female with sleep <6 hr/day: OR, 1.46; 95% CI, 0.96–2.21
 Female with sleep ≥9 hr/day: OR, 1.31; 95% CI, 0.75–2.27
 Age <65 yr with sleep <6 hr/day: OR, 1.34; 95% CI, 0.86–2.09
 Age <65 yr with sleep ≥9 hr/day: OR, 1.33; 95% CI, 0.84–2.41
 Ohkuma et al. (2013)67 Cross-sectional study/Japan Japanese patients with T2DM (n=4,870) Sleep duration was categorized as: <4.5, 4.5–5.4, 5.5–6.4, 6.5–7.4, 7.5–8.4, and ≥8.5 hr/day Self-reported ≥20, 57% Adjusted geometric means (95% CIs) of HbA1c
 Sleep <4.5 hr/day: 7.52 (7.38–7.67)
 Sleep 6.5–7.4 hr/day: 7.32 (7.28–7.37)
 Sleep ≥8.5 hr/day: 7.43 (7.34–7.52)
P for quadratic trend: 0.004
 Wang et al. (2015)89 Cross-sectional study/China Patients with diabetes from the baseline survey of the REACTION Study (n=56,032) Sleep duration was categorized as: <6, 6–7.9, 8–8.9, and ≥9 hr/night;
Reference: 6–7.9 hr/night
Self-reported Sleep <6 hr/night: 61.2±8.8, 37%;
Sleep ≥9 hr/night: 61.4±9.7, 38%;
Reference: 60.5±8.8, 39%
Poor glycemic control (HbA1c ≥7.0%)
 Sleep <6 hr/night: OR, 1.09; 95% CI, 0.99–1.21
 Sleep ≥9 hr/night: OR, 1.11; 95% CI, 1.05–1.18
 Kong et al. (2017)90 Cross-sectional study/Hong Kong Hong Kong Chinese patients with T2DM (n=3,508) Sleep duration: the period between bedtime and wake-up time on weekdays and weekends Self-reported 53.9±8.7, 59% Sleep duration difference between weekdays and weekends is curvilinearly associated with both HbA1c and FPG.
 One hour more sleep during weekends than weekdays was associated with a decrease in HbA1c (−0.13%; 95 % CI, −0.24 to −0.02).

Values are presented as range, mean±standard deviation, or mean (range).

RR, relative risk; CI, confidence interval; HR, hazard ratio; OR, odds ratio; NS, not specified; BMI, body mass index; WC, waist circumference; T2DM, type 2 diabetes mellitus; PSG, polysomnography; IGT, impaired glucose tolerance; FPG, fasting plasma glucose.